|Post IPO Valuation|
|Good Start Genetics||4/12|
|Good Start Genetics||9/10|
Safeguard Scientifics provides growth capital for entrepreneurial and innovative life sciences and technology companies. Safeguard targets life sciences companies in Molecular and Point-of-Care Diagnostics, Medical Devices, Regenerative Medicine and Specialty Pharmaceuticals, and technology companies in Internet / New Media, Financial Services IT and Healthcare IT with capital requirements of up to $25 million. Safeguard participates in expansion financings, corporate spin-outs, management buyouts, recapitalizations, industry consolidations and early-stage financings.
Safeguard has deployed capital in and provided operational expertise and support to hundreds of companies, entrepreneurs and management teams, successfully completing more than 100 M&A transactions and 20 IPOs. Safeguardâ€™s prudent and innovative approach to identifying market leaders in key strategic sectors has spawned household names and industry leaders including Novell, QVC, Cambridge Technology Partners, Internet Capital Group, CompuCom Systems and Traffic.com.
Safeguard Scientifics Elevator PitchAdded: 1/28/11